University of Lübeck

Investment thesis

The University of Lübeck exists to advance translational research in medicine, life sciences, and engineering, bridging the gap between academic discovery and clinical or industrial application. It operates as a public research university with a strategic agenda focused on population health, biomedical technology, and intelligent systems.

• Translational Oncology: The university hosts a dedicated research profile in translational oncology, focusing on moving cancer research from the lab to patient care [1].
• Biomedical Technology & Sensors: Strong research output in sensor networks and biomedical engineering, exemplified by the Institute of Telematics' work on wireless sensor network infrastructure [2].
• Population Health: A defined research profile in population medicine and health services research, addressing broader public health challenges [1].
• Interdisciplinary Collaboration: The university actively manages joint ventures with Fraunhofer, the University Hospital Schleswig-Holstein, and the German Research Centre for Artificial Intelligence, creating a dense innovation ecosystem [1].

Credibility: The university's official website lists these specific research profiles and institutional partnerships, confirming its strategic focus on translational science and technology transfer.

Interconnection: The university’s role as a public institution means it primarily facilitates access to its own research infrastructure and spin-off creation rather than acting as a direct venture fund.

Value add

The University of Lübeck offers significant non-financial value to founders and researchers through its infrastructure, expertise, and network.

• Technology Transfer: The university's technology transfer office provides expert advice on patents, inventions, and spin-off creation, helping founders protect and commercialise IP [1].
• Incubator Access: Founders can access the Gründercube incubator, which offers workspace and support for university-based startups [1].
• Research Infrastructure: Access to specialized facilities like the Central Biobank and clinical study centres accelerates product development in life sciences [1].
• Credibility: Association with a public research university enhances the credibility of research-driven startups in grant applications and investor pitches.

Fit verdict: The University of Lübeck is an ideal partner for deep-tech, med-tech, and AI founders who need access to specialized research infrastructure and academic expertise rather than direct capital.

Founder diligence script:

• Does my startup's technology align with the university's core research profiles in medicine, life sciences, or intelligent systems?
• Have I engaged with the technology transfer office to assess the patentability and ownership of my core IP?
• Can I leverage the university's clinical study centres or biobank for my product development?
• Is my team eligible for or interested in accessing the university's doctoral or postdoctoral talent pool?
• How can I structure a collaborative research agreement to access the university's infrastructure?

Portfolio focus

The university's research and innovation portfolio is heavily concentrated in its core areas of expertise.

• Translational Oncology: Research projects focused on moving cancer research from the lab to clinical application [1].
• Biomedical Technology: Development of medical devices, sensor networks, and cell-based medical technologies [2].
• Intelligent Systems: Research in computer science, AI, and sensor network simulation, as evidenced by the Institute of Telematics' open-source projects [2].
• Population Health: Studies and research aimed at improving public health outcomes and healthcare systems [1].

Interconnection: The portfolio reflects the university's strategic focus on translational science and its strong ties to the regional healthcare and technology sectors.